This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-consensus: Archive
How Much Upside is Left in OppFi (OPFI)? Wall Street Analysts Think 36.05%
by Zacks Equity Research
The mean of analysts' price targets for OppFi (OPFI) points to a 36.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
OPFIPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See an 110.11% Upside in Kamada (KMDA): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at an 110.1% upside potential for Kamada (KMDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
KMDAPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Marex Group PLC (MRX) Could Surge 43.92%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 43.9% upside potential for Marex Group PLC (MRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MRXNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict an 86.05% Upside in XOMA Royalty (XOMA): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for XOMA Royalty (XOMA) points to an 86.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
XOMAPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Enovis (ENOV) Could Rally 69.91%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 69.9% upside potential for Enovis (ENOV). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ENOVPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Elastic (ESTC) Could Surge 40.83%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 40.8% upside potential for Elastic (ESTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ESTCNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Dave & Buster's (PLAY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Dave & Buster's (PLAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PLAYPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Does Bright Minds Biosciences Inc. (DRUG) Have the Potential to Rally 114.07% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at an 114.1% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
DRUGNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Edgewise Therapeutics (EWTX) Could Rally 172.96%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 173% in Edgewise Therapeutics (EWTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
EWTXPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Can SiriusPoint (SPNT) Climb 33.55% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 33.6% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
SPNTPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 31.74% Upside in Integer (ITGR): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Integer (ITGR) points to a 31.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ITGRPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Methanex (MEOH) Have the Potential to Rally 32.08% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 32.1% upside potential for Methanex (MEOH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MEOHNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Oracle (ORCL) to Report Q1 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oracle (ORCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ORCLNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Wall Street Analysts Think Natural Gas Services (NGS) Could Surge 38.57%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 38.6% in Natural Gas Services (NGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NGSPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 26.52% Upside in Hillman Solutions Corp. (HLMN): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in Hillman Solutions Corp. (HLMN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
HLMNPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think El Pollo Loco (LOCO) Could Surge 31.7%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 31.7% upside potential for El Pollo Loco (LOCO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
LOCOPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 39.94% Upside in The Pennant Group (PNTG): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 39.9% upside potential for The Pennant Group (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
PNTGPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does The Beachbody Company (BODI) Have the Potential to Rally 96.55% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for The Beachbody Company (BODI) points to a 96.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BODINegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Deluxe (DLX) Could Surge 36.06%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 36.1% upside potential for Deluxe (DLX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
DLXPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Syndax (SNDX) points to an 112.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
SNDXPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe TTM (TTMI) Could Rally 27.33%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 27.3% in TTM (TTMI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
TTMINegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
How Much Upside is Left in Q2 Holdings (QTWO)? Wall Street Analysts Think 29.72%
by Zacks Equity Research
The consensus price target hints at a 29.7% upside potential for Q2 Holdings (QTWO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
QTWOPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
PASGNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Nexxen International Ltd. Sponsored ADR (NEXN) Have the Potential to Rally 53.34% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in Nexxen International Ltd. Sponsored ADR (NEXN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NEXNNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 32.6% upside potential for ARKO (ARKO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ARKOPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate